Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yohei Mikami

Showing results (121-130 of 124) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 124 results.
Journal of Gastroenterology|February 10, 2023
Correction to: Expert consensus on vaccination in patients with inflammatory bowel disease in JapanTakashi Ishige, Toshiaki Shimizu, Kenji Watanabe, et al.
Journal of Gastroenterology|January 11, 2023
Expert consensus on vaccination in patients with inflammatory bowel disease in JapanTakashi Ishige, Toshiaki Shimizu, Kenji Watanabe, et al.
Nature Communications|June 5, 2023
Bacteriophage therapy against pathological Klebsiella pneumoniae ameliorates the course of primary sclerosing cholangitisMasataka Ichikawa, Nobuhiro Nakamoto, Sharon Kredo-Russo, et al.
Nature|August 8, 2022
DOCK2 is involved in the host genetics and biology of severe COVID-19Ho Namkoong, Ryuya Edahiro, Tomomi Takano, et al.
Pageof 13

Showing results (121-130 of 124) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 124 results.
Journal of Gastroenterology|February 10, 2023
Correction to: Expert consensus on vaccination in patients with inflammatory bowel disease in JapanTakashi Ishige, Toshiaki Shimizu, Kenji Watanabe, et al.
Journal of Gastroenterology|January 11, 2023
Expert consensus on vaccination in patients with inflammatory bowel disease in JapanTakashi Ishige, Toshiaki Shimizu, Kenji Watanabe, et al.
Nature Communications|June 5, 2023
Bacteriophage therapy against pathological Klebsiella pneumoniae ameliorates the course of primary sclerosing cholangitisMasataka Ichikawa, Nobuhiro Nakamoto, Sharon Kredo-Russo, et al.
Nature|August 8, 2022
DOCK2 is involved in the host genetics and biology of severe COVID-19Ho Namkoong, Ryuya Edahiro, Tomomi Takano, et al.
Pageof 13